![]() |
Peter G Levine The Stroke Recovery Blog |
When it comes to spasticity reduction, Botox is the 600 pound gorilla. It is the Oracle. If Oz was the world of spasticity, Botox would be its Wizard. Allergan, the company that makes Botox dictates the conversation. Why? Cold hard cash. Allergan made significantly more than $1 billion in the third quarter of 2012 alone.

Keep in mind that Allergan makes other drugs besides Botox. And spasticity isnt the main reason Botox makes 'em money. The main reason Botox makes money is because of its wrinkle reduction qualities. Bottom line: they have plenty of cash. And they use that cash to influence opinion. This is inevitable, but also unfortunate. The influence that can be bought chips away at a discussion of other possibilities.
What are the other possibilities?
Phenol blocks. In the book "Spasticity: Diagnosis and Management" phenol blocks are called: a "Dying Art" That Merits Revival.
Why does it merit revival? Phenol blocks do pretty much the same thing as Botox for spasticity. But it costs less. Much, much less. This is something you should discuss with your doctor. It may be true that Botox is the best option. But it may save you some money to ask about phenol blocks. How much money is saved?
For muscles in the arm/hand, this is one estimate...
Botox: $1014.84
Phenol: $7.85

During the "vacation" block provide hard work can help permanently reduce spasticity.
Otherwise, it's just a vacation.
See the original article The Problem with Botox
in The Stroke Recovery Blog
No comments:
Post a Comment